Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155003791> ?p ?o ?g. }
- W2155003791 endingPage "14" @default.
- W2155003791 startingPage "6" @default.
- W2155003791 abstract "In order to develop more effective therapeutic vaccines against cancers with high-risk human papillomavirus (HPV) infection, it is crucial to enhance the immunogenicity, eliminate the oncogenicity of oncoproteins, and take a combination of E7- and E6-containing vaccines. It has been shown recently that PE(ΔIII)-E7-KDEL3 (E7), a fusion protein containing the HPV16 oncoprotein E7 and the translocation domain of Pseudomonas aeruginosa exotoxin A, is effective against TC-1 tumor cells inoculated in mice, therefore, we engineered PE(ΔIII)-E6-CRL-KDEL3 (E6), the de-oncogenic versions of the E7 and E6 fusion proteins [i.e. PE(ΔIII)-E7(d)-KDEL3, E7(d), and PE(ΔIII)-E6(d)-CRL-KDEL3, E6(d)] and tested the immunoefficacies of these fusion proteins as mono- and bivalent vaccines. Results indicated that the E7(d) get higher immunogenicity than its wild type and the E6 fusion proteins augmented the immunogenicity and antitumor effects of their E7 counterparts. Furthermore, the bivalent vaccine system E7(d) plus E6(d), in the presence of cisplatin, showed the best tumoristatic and tumoricidal effects against established tumors in vivo. Therefore, it can be concluded that this novel therapeutic vaccine system, upon further optimization, may shed new light on clinical management of HPV-related carcinomas." @default.
- W2155003791 created "2016-06-24" @default.
- W2155003791 creator A5011519137 @default.
- W2155003791 creator A5028015120 @default.
- W2155003791 creator A5029640870 @default.
- W2155003791 creator A5030367664 @default.
- W2155003791 creator A5034340901 @default.
- W2155003791 creator A5046358498 @default.
- W2155003791 creator A5048447893 @default.
- W2155003791 creator A5053202587 @default.
- W2155003791 creator A5053725057 @default.
- W2155003791 creator A5057444662 @default.
- W2155003791 date "2014-01-01" @default.
- W2155003791 modified "2023-10-17" @default.
- W2155003791 title "De-oncogenic HPV E6/E7 vaccine gets enhanced antigenicity and promotes tumoricidal synergy with cisplatin" @default.
- W2155003791 cites W1522781268 @default.
- W2155003791 cites W1966512662 @default.
- W2155003791 cites W1979392487 @default.
- W2155003791 cites W1984512827 @default.
- W2155003791 cites W1987987555 @default.
- W2155003791 cites W1988136894 @default.
- W2155003791 cites W1993568759 @default.
- W2155003791 cites W1995404189 @default.
- W2155003791 cites W2002108471 @default.
- W2155003791 cites W2010402241 @default.
- W2155003791 cites W2011499737 @default.
- W2155003791 cites W2012638373 @default.
- W2155003791 cites W2023539918 @default.
- W2155003791 cites W2025106754 @default.
- W2155003791 cites W2030158066 @default.
- W2155003791 cites W2030560379 @default.
- W2155003791 cites W2034680431 @default.
- W2155003791 cites W2039934202 @default.
- W2155003791 cites W2040332150 @default.
- W2155003791 cites W2046776686 @default.
- W2155003791 cites W2055202552 @default.
- W2155003791 cites W2066332001 @default.
- W2155003791 cites W2070288788 @default.
- W2155003791 cites W2075679064 @default.
- W2155003791 cites W2077155376 @default.
- W2155003791 cites W2082096237 @default.
- W2155003791 cites W2086141003 @default.
- W2155003791 cites W2087295353 @default.
- W2155003791 cites W2098491904 @default.
- W2155003791 cites W2102282815 @default.
- W2155003791 cites W2106586933 @default.
- W2155003791 cites W2126740617 @default.
- W2155003791 cites W2129057663 @default.
- W2155003791 cites W2134631524 @default.
- W2155003791 cites W2138250841 @default.
- W2155003791 cites W2142200682 @default.
- W2155003791 cites W2148461640 @default.
- W2155003791 cites W2160335594 @default.
- W2155003791 cites W4235081779 @default.
- W2155003791 doi "https://doi.org/10.1093/abbs/gmt121" @default.
- W2155003791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24240707" @default.
- W2155003791 hasPublicationYear "2014" @default.
- W2155003791 type Work @default.
- W2155003791 sameAs 2155003791 @default.
- W2155003791 citedByCount "7" @default.
- W2155003791 countsByYear W21550037912014 @default.
- W2155003791 countsByYear W21550037912015 @default.
- W2155003791 countsByYear W21550037912016 @default.
- W2155003791 countsByYear W21550037912017 @default.
- W2155003791 countsByYear W21550037912018 @default.
- W2155003791 countsByYear W21550037912019 @default.
- W2155003791 crossrefType "journal-article" @default.
- W2155003791 hasAuthorship W2155003791A5011519137 @default.
- W2155003791 hasAuthorship W2155003791A5028015120 @default.
- W2155003791 hasAuthorship W2155003791A5029640870 @default.
- W2155003791 hasAuthorship W2155003791A5030367664 @default.
- W2155003791 hasAuthorship W2155003791A5034340901 @default.
- W2155003791 hasAuthorship W2155003791A5046358498 @default.
- W2155003791 hasAuthorship W2155003791A5048447893 @default.
- W2155003791 hasAuthorship W2155003791A5053202587 @default.
- W2155003791 hasAuthorship W2155003791A5053725057 @default.
- W2155003791 hasAuthorship W2155003791A5057444662 @default.
- W2155003791 hasBestOaLocation W21550037911 @default.
- W2155003791 hasConcept C104317684 @default.
- W2155003791 hasConcept C109316439 @default.
- W2155003791 hasConcept C123894998 @default.
- W2155003791 hasConcept C147483822 @default.
- W2155003791 hasConcept C150903083 @default.
- W2155003791 hasConcept C159047783 @default.
- W2155003791 hasConcept C182179738 @default.
- W2155003791 hasConcept C185592680 @default.
- W2155003791 hasConcept C202751555 @default.
- W2155003791 hasConcept C203014093 @default.
- W2155003791 hasConcept C207001950 @default.
- W2155003791 hasConcept C2776694085 @default.
- W2155003791 hasConcept C2778239845 @default.
- W2155003791 hasConcept C2779026604 @default.
- W2155003791 hasConcept C2780868878 @default.
- W2155003791 hasConcept C40767141 @default.
- W2155003791 hasConcept C502942594 @default.
- W2155003791 hasConcept C54355233 @default.
- W2155003791 hasConcept C55493867 @default.
- W2155003791 hasConcept C86803240 @default.